Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic ReviewSummary

• Main Authors: Thergiory Irrazabal, Bhupesh K. Thakur, Kenneth Croitoru, Alberto Martin
• Format: Article
• Language: English
• Published: Elsevier 2021-01-01
• Series: Cellular and Molecular Gastroenterology and Hepatology
• Subjects: Colitis; Inflammatory Bowel Disease; Colorectal Cancer; Antioxidants; DNA Damage
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352345X20302125

Inflammatory bowel disease (IBD) patients have an increased risk of developing colitis-associated colon cancer (CAC); however, the basis for inflammation-induced genetic damage requisite for neoplasia is unclear. Several studies have shown that IBD patients have signs of increased oxidative damage, which could be a result of genetic and environmental factors such as an excess in oxidant molecules released during chronic inflammation, mitochondrial dysfunction, a failure in antioxidant capacity, or oxidant promoting diets. It has been suggested that chronic oxidative environment in the intestine leads to the DNA lesions that precipitate colon carcinogenesis in IBD patients. Indeed, several preclinical and clinical studies show that different endogenous and exogenous antioxidant molecules are effective at reducing oxidation in the intestine. However, most clinical studies have focused on the short-term effects of antioxidants in IBD patients but not in CAC. This review article examines the role of oxidative DNA damage as a possible precipitating event in CAC in the context of chronic intestinal inflammation and the potential role of exogenous antioxidants to prevent these cancers.